Biologicsworldnordics
6th -
7th
March 2024 | 
Copenhagen, Denmark

Facilitating the Development and Manufacturing of High-Quality Biologics for the Emerging Nordics Market

6th -
7th
March 2024 | 
Copenhagen, Denmark
馃搮 Add to Google Calendar
0 +
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies

The 5th Biologics World Nordics 2024 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.This is the only biologics market place in the Nordics area that demonstrates the region's enormous possibilities and provides a full network for Nordic biologic firms wishing to license/partner with large pharma, CROs, and CDMO/CMOs.

Biologics World Nordics 2024

The聽Nordics聽region is playing a critical role in expanding medical knowledge and opening the path for revolutionary medicines that hold promise for patients globally. Explore the exciting progress ofclinical聽studies on biologics and cell and gene therapy products聽from the Nordics biopharma.

High-throughput cell line creation and cell culture have聽considerably sped聽the discovery and development of novel biologics, improving the efficiency and scalability of biopharmaceutical manufacturing.Know-how聽on the latest development of cell line development and cell culture technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically聽feasible.

Cost optimisation strategies coupled with the聽utilisation聽of advanced purification platforms have become essential for the biopharmaceutical industry, enabling efficient and economical production of high-quality therapeutics.聽Immerse into the most focused biologics downstream processing with the聽ultimate goal聽of meeting quality and purity requirements of biologics drug products at lower cost.

Listen from the Nordic region聽which聽demonstrated聽exceptional process in commercialising its R&D聽objectives, capitalising on its strong innovation ecosystem, supportive regulatory framework, and strategic alliances to translate聽cutting-edge聽research into marketable products and solutions.

The Nordic biologics sector is poised to drive transformative advances in medicine, create new market opportunities, and address unmet medical needs on a global scale by聽leveraging聽the region’s聽expertise聽in biologics R&D and manufacturing,聽cutting-edge聽research capabilities, and collaborative approach to healthcare innovation.

THANK YOU TO OUR SPONSORS









SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Annika-Ericsson_photo_profile-3

Annika Ericsson

Director Preclinical Development, CombiGene, Sweden

Sweden
Ashesh-Kumar_photo_profile

Ashesh Kumar

CEO, Paras Biopharmaceuticals, Finland

Bjorn-Voldborg_photo_profile

Bjorn Voldborg,

Head of The National Biologics Facility, DTU Bioengineering, Denmark

Evelina-Vagesjo_photo_profile-2

Evelina Vagesjo

CEO, Ilya Pharma, Sweden

Fabio-Rosa_photo_profile-3

Fabio Rosa

Co-founder and Head of Research, Asgard Therapeutics, Sweden

Sweden
Francois-Martelet_photo_profile

Fran莽ois Martelet

Chief Executive Officer, Scandion Oncology, Denmark

Huram-Konjen_photo_profile

Huram Konjen

CEO, Dianox, Denmark

Jan-Talts_photo_profile

Jan Talts

COO, Amniotics, Sweden

Sweden
Jens-Kringelum_photo_profile

Jens Kringelum

VP, AI & Innovation, Evaxion Biotech, Denmark

Denmark
Julian-Read_photo_profile-3

Julian Read

CEO , Simris Alg, Sweden

Sweden
no-picture

Liselotte Larsson

COO

Cantargia
Sweden
no-picture

Luiza Jedlina

CSO, Co-Founder and Inventor

Aptahem
Sweden
Mathias-Svahn_photo_profile

Mathias Svahn

Ph.D., CEO, NextCell Pharma, Sweden

Sweden
Mats-Lundgren_photo_profile-3

Mats Lundgren

Vice President Research and Development, Abera Bioscience, Sweden

Sweden
Peter-Ellmark

Peter Ellmark

Chief Science Officer

Alligator Bioscience
Sweden
Peter-Holst_photo_profile

Peter Holst

Chief Scientific Officer, InProTher, Denmark

Petter-Bjorquist_photo_profile-2

Petter Bjorquist

CEO, Verigraft, Sweden

Sweden
Rasmus-Beedholm-Ebsen_photo_profile

Rasmus Beedholm-Ebsen

Senior Advisor - Life Science, Invest in Denmark (Ministry of Foreign Affairs of Denmark), Denmark

Sara-Mangsbo_photo_profile-3

Sara Mangsbo

Senior Lecturer Antibody Drugs, Uppsala University, Sweden

Sweden
Soren-Brengenholtt_photo_profile

Soren Brengenholtt

Chief Executive Officer, Alligator Bioscience, Denmark

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA (ACADEMIC & RESEARCH INSTITUTES)
Limited Super (By 31st Oct 2023)
拢 1,050 

Limited Special (By 30th Nov 2023)
拢 1,250 

Early Bird (By 2nd Feb 2024)
拢 1,450 

Standard Price
拢 1,650 

Limited Group Packages

  • BUY2,GET3
  • BUY3,GET5
SERVICE & SOLUTIONS PROVIDERS
Limited Super (By 31st Oct 2023)
拢 2,250 

Limited Special (By 30th Nov 2023)
拢 2,450 

Early Bird (By 2nd Feb 2024)
拢 2,650 

Standard Price
拢 2,850 

Group Discount for Solution Providers & General Public:
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

CCO,  
Regional Commercial Director  

Cold Chain Technologies

BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe,  
Director Business Development & Channel Sales  

MasterControl

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

Senior,  
Technical Account Specialist  

West Pharmaceutical Services

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Nick Kotlarski,  
President, VP of BioManufacturing  

Bioworkshops Limited

The conference was a great success and fruitful.

Cai Bao,  
VP of BioManufacturing  

Biocon

Fantastic conference with professional team.

Julio Lin,  
VP  

Blue Blood Biotech

Informative session. Exhibition was well targeted and diverse. Presenters shared latest development

Sankar Dharmaraj,  
Head, GMP Operations  

Hilman Laboratories

It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!

MD Atiqur Rahman,  
Senior Executive Officer, Professional (Sterile)  

Incepta

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

Koh Wei Jet,  
Sanofi  

EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

Chris Lee,  
Site head, Singapore Development and Manufacturing  

WuXi Biologics

The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.

Chandrakant Kathote,  
Site Head & Vice President  

Lupin Ltd

It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.

Dr. Swapan Kumar Jana,  
Director R&D and Manufacturing  

Serum Institute Of India Pvt. Limited

A well organized ambitious meeting. I hope it will continue to develop in the future.

Jean Francois Dierick,  
Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development  

GSK Vaccines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Download Featured Content Form

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit Brochure

Download Form